Tag Archives: KPMG

Pharma to Flash the Cash to Counter Bleak Short-Term Outlook

Nearly two-thirds of US senior pharmaceutical executives surveyed by last month foresee a ‘full economic recovery’ by the end of 2013, with more than half of these pointing to an upturn in the industry’s fortunes by the end of next year. However, 27 percent of the 100 executives interviewed by KPMG for its Industry Pulse Survey [...]
Posted in Strategy | Also tagged , , , | Leave a comment